Thank you, Tech, for clearing the air! I have one question that I’ve been thinking about. Someone posted about the Eli Lily drug in the same population with 400+ patients with very good results. They thought they couldn’t get EUA. Would it be different for our moderate trial? Or would we need to do a huge Gilead-like trial? Forgive me if it’s a dumb question.